プロバイオティクスと健康に関するジャーナル
オープンアクセス

概要

Further Insights into the Pathogenesis of Cardiac Damage in SARS-CoV-2 Infection

Margo E Hammond1, Erik D Christensen2, Michael Belenky2, Kevin Shah3, M Elizabeth H Hammond3*

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) continues to cause significant death and disability globally. After initial infection, approximately one fourth of patients develop cardiovascular complications including myocardial infarctions, stroke, arrhythmia, heart failure, and sudden cardiac death. Recent reviews and studies highlight the significance of innate immune mediators and cells in provoking microvascular injury in the heart and lungs of infected patients.